Drug Type Cell therapy |
Synonyms |
Target |
Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypersensitivity | Phase 3 | AU | - | |
Autoimmune Diseases | Discovery | AU | - | |
Autoimmune Diseases | Discovery | AU | - | |
Autoimmune Diseases | Discovery | AU | - | |
Graft Rejection | Discovery | AU | - | |
Graft Rejection | Discovery | AU | - | |
Graft Rejection | Discovery | AU | - | |
Hypersensitivity | Discovery | AU | - | |
Hypersensitivity | Discovery | AU | - |